To assess the field of muscular and anhidrotic effects of @ commercial preparations of BoNT-A ( incobotulinumtoxinA : Xeomin -LSB- XEO -RSB- ; abobotulinumtoxinA : Dysport -LSB- DYS -RSB- ) administered to the upper third of the face .